Screener
Unicycive Therapeutics, Inc. UNCY Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$0.52Beat by $0.18
EPS estimate-$0.70
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$902.8K
EPS estimate-$0.32
Versus estimates
Diluted EPS
FAQ
- When did Unicycive Therapeutics, Inc. report Q2 2025 earnings?
- Unicycive Therapeutics, Inc. (UNCY) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Unicycive Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Unicycive Therapeutics, Inc. reported eps of $-0.52 for Q2 2025.
- Did Unicycive Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.70 by $0.18.
- How did Unicycive Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 246.7% from $-0.15.
- Where can I find Unicycive Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-076066) and the 10-Q periodic report (0001213900-25-076007) directly on SEC EDGAR. The filing index links above go to sec.gov.
